Drug Shortage Report for CYANOCOBALAMIN INJECTION USP
Report ID | 200983 |
Drug Identification Number | 02463393 |
Brand name | CYANOCOBALAMIN INJECTION USP |
Common or Proper name | CYANOCOBALAMIN INJECTION USP |
Company Name | HIKMA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | VITAMIN B12 |
Strength(s) | 1000MCG |
Dosage form(s) | SOLUTION LIQUID |
Route of administration | SUBCUTANEOUS INTRAMUSCULAR SUBCUTANEOUS INTRAMUSCULAR |
Packaging size | 1mL |
ATC code | B03BA |
ATC description | VITAMIN B12 AND FOLIC ACID |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2023-09-01 |
Actual start date | |
Estimated end date | 2023-11-30 |
Actual end date | 2023-12-14 |
Shortage status | Resolved |
Updated date | 2023-12-15 |
Company comments | Product on allocation at distributors. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 5995 AVEBURY ROAD, SUITE 804 MISSISSAUGA, ONTARIO CANADA L5R 3P9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2023-12-15 | French | Compare |
v4 | 2023-12-15 | English | Compare |
v3 | 2023-09-02 | English | Compare |
v2 | 2023-08-03 | French | Compare |
v1 | 2023-08-03 | English | Compare |
Showing 1 to 5 of 5